This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nagy, P. Articles by Thorgeirsson, S. S. Search for Related Content PubMed PubMed Citation Articles by Nagy, P. Articles by Thorgeirsson, S. S.

Cellular Distribution of c-myc Transcripts during Chemical Hepatocarcinogenesis in Rats

Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892

The expression of cellular myc (c-myc) was studied during early and late stages of chemical hepatocarcinogenesis in the rat using Northern blot analysis and in situ hybridization. Hepatocarcinogenesis was induced according to the resistant hepatocyte model of Solt and Farber. An uninitiated version of this model was also used to examine the expression of c-myc during proliferation and differentiation of oval cells. The expression of c-myc was increased throughout hepatocarcinogenesis starting with early preneoplastic foci and oval cells. Similar levels of c-myc transcripts were detected in oval cells and basophilic hepatocytes generated by the uninitiated version of the protocol as were found in preneoplastic foci and oval cells during hepatocarcinogenesis. Whereas c-myc expression remained elevated in late noplastic nodules and carcinomas, it gradually declined in both "remodeling" nodules and uninitiated livers. Our data indicate that c-myc expression is elevated during the undifferentiated stages of hepatocyte development. Furthermore, the data support the hypothesis that a critical early step in chemical hepatocarcinogenesis involves a block in the normal differentiation program of the hepatocytes.

¹ To whom requests for reprints should be addressed, at the National Cancer Institute, Bldg. 37, Room 3C28, Bethesda, MD 20892.

Received 2/16/88. Revised 6/17/88. Accepted 7/ 6/88.

This article has been cited by other articles:

				S. Kaur, F. Wang, M. Venkatraman, and M. Arsura X-linked Inhibitor of Apoptosis (XIAP) Inhibits c-Jun N-terminal Kinase 1 (JNK1) Activation by Transforming Growth Factor {beta}1 (TGF-{beta}1) through Ubiquitin-mediated Proteosomal Degradation of the TGF-{beta}1-activated Kinase 1 (TAK1) J. Biol. Chem., November 18, 2005; 280(46): 38599 - 38608. [Abstract] [Full Text] [PDF]

				L. G. Cavin, F. Wang, V. M. Factor, S. Kaur, M. Venkatraman, S. S. Thorgeirsson, and M. Arsura Transforming Growth Factor-{alpha} Inhibits the Intrinsic Pathway of c-Myc-Induced Apoptosis through Activation of Nuclear Factor-{kappa}B in Murine Hepatocellular Carcinomas Mol. Cancer Res., July 1, 2005; 3(7): 403 - 412. [Abstract] [Full Text] [PDF]

				E. R. Lemmer, P. de la Motte Hall, N. Omori, M. Omori, E. G. Shephard, W. C.A. Gelderblom, J. P. Cruse, R. A. Barnard, W. F.O. Marasas, R. E. Kirsch, et al. Histopathology and gene expression changes in rat liver during feeding of fumonisin B1, a carcinogenic mycotoxin produced by Fusarium moniliforme Carcinogenesis, May 1, 1999; 20(5): 817 - 824. [Abstract] [Full Text] [PDF]